Generics in Indonesia - Market Summary, Competitive Analysis and Forecast to 2025
Generics in Indonesia - Market Summary, Competitive Analysis and Forecast to 2025Summary
Generics in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Indonesian generics market had total revenues of $1.3bn in 2020, representing a compound annual growth rate (CAGR) of 11.6% between 2016 and 2020.
- Market consumption volume increased with a CAGR of 1% between 2016 and 2020, to reach a total of 49.3% in 2020.
- The growth of the Indonesian market has largely been driven by the Universal Health Coverage scheme (Jaminan Kesehatan Nasional, JKN), which prioritizes the use of generics.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Indonesia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Indonesia
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia generics market with five year forecasts
Reasons to Buy
- What was the size of the Indonesia generics market by value in 2020?
- What will be the size of the Indonesia generics market in 2025?
- What factors are affecting the strength of competition in the Indonesia generics market?
- How has the market performed over the last five years?
- How large is Indonesia’s generics market in relation to its regional counterparts?
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.